Policy & Regulation
Smiths Detection's BioFlash detects airborne SARS-CoV-2 variants
13 October 2021 -

Threat detection company Smiths Detection revealed on Wednesday that its BioFlash air sampler can detect the SARS-CoV-2 Alpha variant (B.1.1.7), Beta variant (B.1.351), Gamma variant (P.1), the Kappa variant (B1.617.1), Delta (B.1.617.2) and Delta plus variant (B.1.617.2.1).

The company is currently confirming the ability to detect the Lambda variant, with results likely available in Autumn.

In January 2021, the company announced its BioFlash was capable of detecting airborne SARS-CoV-2 by the US Army of Medical Research Institute of Infectious Diseases (USAMRIID).

BioFlash has successfully been used by several Universities to stop the spread of COVID-19 following airborne detection in several campus buildings, concluded the company.